Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Göran Eckerwall"'
Autor:
Ulrika Larsdotter Nilsson, Göran Eckerwall, Rosa Lamarca, Karolina Rask, Jan Olof Svensson, Pablo Forte, Michael Gillen, Joanna Burke
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 52:7-17
Introduction: Many patients with chronic obstructive pulmonary disease or asthma experience difficulties in coordinating inhalation with pressurized metered-dose inhaler (pMDI) actuation. The use of a spacer device can improve drug delivery in these
Autor:
Leif Bjermer, Kajs Marie Schützer, Maarten van den Berge, Dirkje S. Postma, Marie Carlholm, Jonas Román, Louis-Philippe Boulet, Göran Eckerwall, Tore Persson, Paul M. O'Byrne, Ola Beckman, Gail M. Gauvreau
Publikováno v:
Pulmonary Pharmacology & Therapeutics, 44, 1-6. ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD
Background/Objective: To demonstrate therapeutic equivalence of terbutaline via two different Turbuhaler((R)) devices by evaluating its protective effect against methacholine-induced bronchoconstriction in stable asthma.Methods: In this double-blind,
Autor:
Michael, Gillen, Pablo, Forte, Jan Olof, Svensson, Rosa, Lamarca, Joanna, Burke, Karolina, Rask, Ulrika, Larsdotter Nilsson, Göran, Eckerwall
Publikováno v:
Pulmonary pharmacologytherapeutics. 52
Many patients with chronic obstructive pulmonary disease or asthma experience difficulties in coordinating inhalation with pressurized metered-dose inhaler (pMDI) actuation. The use of a spacer device can improve drug delivery in these patients. The
Autor:
Miguel J. Lanz, Göran Eckerwall, Rosa Lamarca, Ileen Gilbert, Margareta Puu, Carin Jorup, Kristina Sandin, David S. Pearlman, J. McLaren
Publikováno v:
Annals of Allergy, Asthma & Immunology.
Background The efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler (pMDI) have been demonstrated in patients with asthma at least 12 years old. Objective To evaluate the efficacy of 2 formoterol doses added to budesonide as
Publikováno v:
Allergy and Asthma Proceedings. 35:134-140
Dose-response of formoterol via pressurized metered-dose inhaler (pMDI) has not been determined in asthmatic pediatric patients aged 6 to
Autor:
Leif, Bjermer, Gail M, Gauvreau, Dirkje S, Postma, Paul M, O'Byrne, Maarten, van den Berge, Louis-Philippe, Boulet, Ola, Beckman, Tore, Persson, Jonas, Román, Marie, Carlholm, Kajs-Marie, Schützer, Göran, Eckerwall
Publikováno v:
Pulmonary pharmacologytherapeutics. 44
To demonstrate therapeutic equivalence of terbutaline via two different TurbuhalerIn this double-blind, double-dummy, multicentre, single-dose, 4-way crossover study, patients with stable mild-to-moderate asthma (FEV60 patients (mean age 31.1 years [
Autor:
Tore Lind, Mia Fjellman, Göran Eckerwall, Kerstin Röhss, Anna Backlund, Clive H. Wilder-Smith
Publikováno v:
Clinical Drug Investigation. 28:333-343
Background and objective: In patients with gastro-oesophageal reflux disease (GORD), dose escalation or drug switching may be considered in those with symptoms that persist despite standard-dose proton pump inhibitor (PPI) therapy. This study set out
Publikováno v:
International Journal of Clinical Pharmacology and Therapeutics
Objective: The efficacy and safety of budesonide/formoterol maintenance and reliever therapy (MRT) has been demonstrated in phase III clinical studies, but limited data are available in a real-life setting. We examined the pattern of maintenance and
Publikováno v:
Respiratory medicine. 109(2)
SummaryRationaleTo assess equivalence of twice daily (bid) budesonide/formoterol (BUD/FM) 160/4.5 μg via breath-actuated metered-dose inhaler (BAI) versus pressurized metered-dose inhaler (pMDI).MethodsThis 12-week, double-blind, multicenter, parall
Publikováno v:
Journal of Pediatric Orthopaedics B. 6:239-244
We studied 21 children with Legg-Calvé-Perthes Disease with a prognostically poor development, including lateralization, poor containment, anterolateral flattering, and deformation of the femoral head, as evaluated on serial magnetic resonance (MR)